Gabriella Rosen Kellerman is an author, entrepreneur, start-up executive, and Harvard-trained physician with expertise in behavioral and organizational, change, digital health, wellbeing, and AI. Her first book, Tomorrowmind, co-authored with Professor Martin Seligman, will be published by Atria in January 2023. She has served as Chief Product Officer and Chief Innovation Officer at BetterUp, a transformation platform for global professionals, and as Head of BetterUp Labs, BetterUp’s research arm, which studies whole person development in partnership with labs at Harvard, University of Pennsylvania, Stanford, and many more.

Gabriella began her career in psychiatry and fMRI research and has worked on global mental health policy and interventions for the World Health Organization. She is the founding CEO of the healthcare technology company LifeLink, former Director of Health and Quality Products at Castlight Health, and a serial executive at, and advisor to, healthcare, coaching, and behavior change technology companies.

As a thought leader, Gabriella is published widely for both popular and technical audiences in The Atlantic Online, Scientific American Mind, JAMA, and the Harvard Business Review. She has been profiled in Inc Magazine, and her work has been featured on CNBC, Entrepreneur, and Forbes.Gabriella holds an MD with honors from Mount Sinai School of Medicine, and a BA summa cum laude from Harvard University.

She completed her internship in psychiatry at UCSD and holds a California physician's license. Gabriella was awarded Harvard's Captain Jonathan Fay Prize; Hoopes Prize; Rothschild Prize; and Joseph Garrison Parker Prizes for her research. She received both the Eben-Fiske Harvard-Cambridge Fellowship and Frank Knox Memorial Fellowships for post-graduate studies. At Mount Sinai, Gabriella was honored with a Tylenol scholarship and the Gold Humanism award. In 2021, she was named to both the Software Report’s top 50 Women in Software and to the Anchor List for Product.